Resistance to EGFR kinase inhibitors appears to be invariable in the treatment of non-small cell lung cancer. Several mechanisms have been described. Here, we report the first case of histologic transformation of EGFR mutant lung adenocarcinoma without prior exposure to EGFR inhibition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330183 | PMC |
http://dx.doi.org/10.1016/j.lungcan.2017.01.005 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!